XBiotech Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
XBiotech Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2014 to Q2 2024.
  • XBiotech Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $1.94M, a 57.8% decline year-over-year.
  • XBiotech Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $8.13M, a 14.9% decline year-over-year.
  • XBiotech Inc. annual Nonoperating Income (Expense) for 2023 was $13.2M, a 1363% increase from 2022.
  • XBiotech Inc. annual Nonoperating Income (Expense) for 2022 was $902K.
  • XBiotech Inc. annual Nonoperating Income (Expense) for 2021 was -$376K, a 107% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $8.13M $1.94M -$2.65M -57.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $10.8M $876K -$2.42M -73.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $13.2M $3.85M -$1.68M -30.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-15
Q3 2023 $14.9M $1.46M +$5.33M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $9.55M $4.59M +$6.75M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $2.8M $3.29M +$1.9M +137% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $902K $5.54M +$6.01M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 -$5.11M -$3.87M -$2.54M -192% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$2.57M -$2.16M -$3.07M -336% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $507K $1.39M +$883K +174% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$376K -$474K -$3.3M -117% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 $2.93M -$1.32M -$2.8M -190% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $5.73M $914K +$1.58M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $4.15M $508K -$1.3M -71.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $5.45M $2.83M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 $1.48M +$1.52M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$662K -$816K -530% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $1.81M +$1.86M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q3 2019 $53K -$39K -$103K -161% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $156K $154K +$440K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$284K -$59K -$140K -173% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$144K -$3K -$261K -101% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-16
Q3 2018 $117K $64K -$324K -83.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $441K -$286K -$841K -152% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $1.28M $81K +$373K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $909K $258K +$215K +500% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-16
Q3 2017 $694K $388K +$413K Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-31
Q2 2017 $281K $555K +$562K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$281K -$292K -$283K -3144% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $2K $43K -$138K -76.2% Oct 1, 2016 Dec 31, 2016 10-K/A 2019-03-15
Q3 2016 $140K -$25K -$103K -132% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $243K -$7K +$316K +97.8% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$73K -$9K -$100K -110% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $27K $181K +$144K +389% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-16
Q3 2015 -$117K $78K +$61K +359% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$178K -$323K -$322K -32200% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 $144K $91K +$90K +9000% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 $54K $37K Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 $17K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 -$1K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 $1K Jan 1, 2014 Mar 31, 2014 10-Q/A 2015-06-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.